Related Experiment Video
Updated: Feb 8, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Anticancer therapy SMRT-ens up: targeting the BCL6-SMRT interaction in B cell lymphoma
Leigh A Compton1, Scott W Hiebert
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Abstract:
Transcription factors have proven to be difficult targets for the development of small-molecule drugs. In this issue of Cancer Cell, Cerchietti et al. identify and characterize a specific, small-molecule inhibitor of BCL6, an oncogenic transcriptional repressor, that has high clinical promise for treating diffuse large B cell lymphoma.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Co-activators and Co-repressors
Gene Therapy
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Group Therapy

